Our goal: develop innovative molecular solutions to advance the diagnosis of infectious diseases and antibiotic resistances
Mobidiag is a commercial stage, fast-growing Finnish-French biotechnology company. At Mobidiag, we develop and market innovative diagnostic solutions for Gastrointestinal Infections, Antimicrobial Resistance Management, Hospital Associated Infections (HAIs), Respiratory Infections and Sepsis.
Based on well-established qPCR and microarray technologies, Mobidiag offers a broad range of tests and instruments. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and antibiotic resistances.
Established in 2000, Mobidiag has served the European clinical diagnostics market with its multiplex Prove-it™ product family since 2008.
In 2013, Mobidiag (Finland) merged with a diagnostic platform developer Genewave (France) and a stool-based clinical assay development company Amplidiag (Finland). As a result, complementing capabilities and offering were gathered to offer industry-leading diagnostic solutions.
Combining expertise in sales, marketing, business, molecular diagnostics, microbiology, software development, bioinformatics, biochemistry and engineering, Mobidiag is able to manufacture and commercialise its own proprietary solutions: Amplidiag® and Novodiag®.
Our mission at Mobidiag
At Mobidiag, we work to address the unmet need for high information-density, easy to use and affordable molecular diagnostic tools. We strive to enable the rapid treatment and triage of patients at the point of impact. Overall, we want to improve the quality and efficiency of healthcare and aid in the combat against spreading and emerging antimicrobial resistances. In order to do so, we work closely with distinguished clinical, academic and industrial partners to deliver the most relevant and highest-value solutions to our customers throughout the world.
Mobidiag, part of a dynamic and innovative ecosystem
Mobidiag headquarters are located in the largest innovation hub in the Nordic countries. The city of Espoo aims at solving the challenges of a sustainable future, and create new smart services and jobs.
Home of Nokia, Kone, VTT Technical Research Centre of Finland, Angry Birds and many more high-tech companies, Mobidiag has been able to grow in a dynamic ecosystem and partner with leaders in the field to bring state-of-the-art technologies.
Learn more about the Espoo Innovation Garden.